NYSE - Delayed Quote • USD
STERIS plc (STE)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 6:13 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 6 | 7 | 7 |
Avg. Estimate | 2.4 | 2.2 | 8.65 | 9.52 |
Low Estimate | 2.36 | 2.11 | 8.62 | 9.39 |
High Estimate | 2.42 | 2.25 | 8.67 | 9.65 |
Year Ago EPS | 2.3 | 2 | 8.2 | 8.65 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 4 | 8 | 8 |
Avg. Estimate | 1.45B | 1.38B | 5.47B | 5.83B |
Low Estimate | 1.42B | 1.36B | 5.45B | 5.77B |
High Estimate | 1.46B | 1.4B | 5.5B | 5.87B |
Year Ago Sales | 1.38B | 1.21B | 4.96B | 5.47B |
Sales Growth (year/est) | 4.40% | 14.10% | 10.40% | 6.60% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 2.15 | 1.87 | 2 | 2.17 |
EPS Actual | 2.3 | 2 | 2.03 | 2.22 |
Difference | 0.15 | 0.13 | 0.03 | 0.05 |
Surprise % | 7.00% | 7.00% | 1.50% | 2.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 2.4 | 2.2 | 8.65 | 9.52 |
7 Days Ago | 2.4 | 2.2 | 8.65 | 9.52 |
30 Days Ago | 2.42 | 2.21 | 8.66 | 9.53 |
60 Days Ago | 2.42 | 2.21 | 8.66 | 9.53 |
90 Days Ago | 2.47 | 2.2 | 8.66 | 9.51 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | STE | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 4.30% | -- | -- | 1.60% |
Next Qtr. | 10.00% | -- | -- | 10.50% |
Current Year | 5.50% | -- | -- | 5.20% |
Next Year | 10.10% | -- | -- | 13.30% |
Next 5 Years (per annum) | 10.00% | -- | -- | 11.22% |
Past 5 Years (per annum) | 12.11% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Reiterates | Needham: Hold | 4/12/2024 |
Reiterates | Stephens & Co.: Overweight to Overweight | 2/9/2024 |
Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/8/2024 |
Initiated | Keybanc: Overweight | 2/6/2024 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/4/2023 |
Reiterates | JMP Securities: Market Outperform to Market Outperform | 11/9/2023 |
Related Tickers
LIVN LivaNova PLC
52.33
-0.82%
AXNX Axonics, Inc.
66.95
-0.15%
OFIX Orthofix Medical Inc.
13.10
+0.61%
GMED Globus Medical, Inc.
50.35
-0.79%
UFPT UFP Technologies, Inc.
207.92
-4.51%
EW Edwards Lifesciences Corporation
85.94
-0.59%
CNMD CONMED Corporation
72.64
+2.19%
ZBH Zimmer Biomet Holdings, Inc.
119.43
+0.08%
SNN Smith & Nephew plc
23.84
-0.71%
ATEC Alphatec Holdings, Inc.
12.54
+1.62%